Ahrensburg, Germany
Velocity Clinical Research Germany GmbH
Founded in 1999 as The Pulmonary Research Institute at the LungenClinic Grosshansdorf and acquired by Velocity Clinical Research in 2024, the experienced team at Velocity’s dedicated research site in Ahrensburg conducts clinical trials across a broad variety of indications, and specializes in pulmonary diseases. By developing strong working relationships with local communities and a robust patient database, Velocity’s Ahrensburg staff provides fast, accurate patient enrollment support, even for diverse populations.
Our Ahrensburg team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research. With decades of research experience shared among our investigators in Ahrensburg, Velocity will deliver the right patients, investigators, and research staff for your next research program.
Velocity Clinical Research Germany GmbH
Klaus-Groth-Strasse 2-4, 2. Etage, Ahrensburg, Germany 22926
Phone: 0049-4102-8881-0
Our experienced research team in Ahrensburg
The Velocity Ahrensburg team of physician investigators and clinical research professionals are experienced clinical researchers. All physicians are board certified in their specialty area(s) and all research staff is trained in clinical research regulations, including GCP and HIPAA. Training records and certifications are maintained. Our clinical team is dedicated to conducting quality research in a professional and caring environment and strives on collecting quality data.
-
Medical Director, Principal Investigator
Prior to joining Velocity, Dr. Watz co-led the Pulmonary Research Institute at the LungeClinic Grosshansdorf (PRI) since 2007. Under his lead, along with his colleague, Dr. Kirsten, PRI conducted over 300 studies, as well as contributed to more than 250 publications and over 300 conferences since then. Dr. Watz is a pulmonologist and internist with experience in many pulmonology indications, including COPD, bronchial asthma, bronchiectasis and pulmonary fibrosis, sarcoidosis, lymphangioleiomyomatosis, and pulmonary hypertension in fibrosing lung diseases. -
Principal Investigator, Site Director
Prior to joining Velocity, Dr. Kirsten co-led the Pulmonary Research Institute at the LungeClinic Grosshansdorf (PRI) since 2007. Under her lead, along with her colleague, Dr. Watz, PRI conducted over 300 studies, as well as contributed to more than 250 publications and over 300 conferences since then. Dr. Kirsten is a pulmonologist and internist with experience in many pulmonology indications, including COPD, bronchial asthma, bronchiectasis and pulmonary fibrosis, sarcoidosis, lymphangioleiomyomatosis, and pulmonary hypertension in fibrosing lung diseases.
Ahrensburg facility features
The Velocity Clinical Research Germany GmbH facility is designed for the ease and comfort of study participants and to allow optimal efficiencies in performing clinical trials. Features at this site include:
• Private examination/consultation rooms
• Comfortable patient reception areas
• Facilities for extended-stay pharmacokinetic studies
• Parking
• Nursing station
• Secure monitoring rooms or workstations with phone & high-speed internet access
• Multiple individual & secure workstations for research staff
• Regulatory document processing area
• Electronic data capture (EDC) capabilities
• Secure record storage
• CLIA certified research laboratory or clinical laboratory with CLIA waiver
• Ambient and refrigerated centrifuge
• Secured & temperature controlled investigational product storage with pharmaceutical refrigerator & freezer
• Freezers equipped for laboratory specimens at -20 & -70 degrees Celsius
• Backup generator/power source in the event of site power loss
• Standard medical equipment, including ECG and Holter machines, digital and analog scales